Literature DB >> 9345320

Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha.

X Zi1, H Mukhtar, R Agarwal.   

Abstract

In this study we describe exceptionally high protective effects of silymarin, a flavonoid antioxidant isolated from milk thistle, against 12-O-tetradecanoylphorbol 13-acetate (TPA)- and okadaic acid (OA)-caused tumor promotion in SENCAR mouse skin. Pre-application of silymarin to that of TPA in 7, 12-dimethylbenz(a)anthracene (DMBA)-initiated mouse skin resulted in almost complete protection in terms of tumor incidence (85%) as well as multiplicity (94%). In OA-caused tumor promotion studies, application of silymarin prior to that of OA in DMBA-initiated mouse skin resulted in a complete protection against tumorigenicity. We next assessed the effect of silymarin on TPA- and OA-caused induction of mRNA expression of tumor necrosis factor alpha (TNF alpha) which is an endogenous tumor promoter and a central mediator of tumor promotion in vivo in the case of both TPA and OA tumor promotion. Topical application of silymarin on mouse skin prior to that of TPA or OA resulted in a highly significant to complete inhibition in a dose-dependent manner against both TPA- and OA-caused induction of TNF alpha mRNA expression in mouse epidermis. These results indicate that silymarin exerts novel chemopreventive effects against tumorigenicity by inhibiting endogenous tumor promoter TNF alpha. Additional studies are warranted in other tumor models to further evaluate the cancer chemopreventive effect of silymarin and to define the involvement of TNF alpha as a molecular target for such an effect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345320     DOI: 10.1006/bbrc.1997.7375

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Silymarin and epithelial cancer chemoprevention: how close we are to bedside?

Authors:  Manjinder Kaur; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-15       Impact factor: 4.219

Review 2.  Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Authors:  Tomas Koltai; Larry Fliegel
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

Review 3.  Cosmeceuticals and silibinin.

Authors:  Rana P Singh; Rajesh Agarwal
Journal:  Clin Dermatol       Date:  2009 Sep-Oct       Impact factor: 3.541

Review 4.  Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview.

Authors:  Divya Singh; William C Cho; Ghanshyam Upadhyay
Journal:  Front Physiol       Date:  2016-01-26       Impact factor: 4.566

5.  In vitro evaluation of antioxidant activity of Cordia dichotoma (Forst f.) bark.

Authors:  Pankaj B Nariya; Nayan R Bhalodia; Vinay J Shukla; Rabinarayan Acharya; Mukesh B Nariya
Journal:  Ayu       Date:  2013-01

6.  Protective effects of silymarin on fumonisin B₁-induced hepatotoxicity in mice.

Authors:  Mahmut Sozmen; Alparslan Kadir Devrim; Recai Tunca; Murat Bayezit; Serpil Dag; Dinc Essiz
Journal:  J Vet Sci       Date:  2013-10-18       Impact factor: 1.672

7.  Silibinin suppresses TNF-alpha-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway.

Authors:  Sangmin Kim; Min Gew Choi; Hye Sook Lee; Se Kyung Lee; Sung Hoon Kim; Wan Wook Kim; Sung Mo Hur; Jung-Han Kim; Jun-Ho Choe; Seok Jin Nam; Jung-Hyun Yang; Sung Kim; Jeong Eon Lee; Jee Soo Kim
Journal:  Molecules       Date:  2009-10-26       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.